Texas Yale Capital Corp’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-70,000
Closed -$144K 508
2025
Q4
$144K Hold
70,000
﹤0.01% 486
2025
Q3
$243K Hold
70,000
0.01% 439
2025
Q2
$154K Hold
70,000
0.01% 456
2025
Q1
$81.2K Hold
70,000
﹤0.01% 443
2024
Q4
$88.9K Hold
70,000
﹤0.01% 453
2024
Q3
$239K Hold
70,000
0.01% 422
2024
Q2
$327K Hold
70,000
0.02% 364
2024
Q1
$519K Hold
70,000
0.02% 324
2023
Q4
$709K Hold
70,000
0.03% 284
2023
Q3
$546K Hold
70,000
0.02% 300
2023
Q2
$576K Hold
70,000
0.03% 298
2023
Q1
$508K Hold
70,000
0.03% 322
2022
Q4
$621K Hold
70,000
0.04% 301
2022
Q3
$857K Hold
70,000
0.05% 250
2022
Q2
$828K Buy
70,000
+20,000
+40% +$268K 0.05% 254
2022
Q1
$951K Buy
50,000
+10,000
+25% +$186K 0.05% 245
2021
Q4
$1.06M Buy
40,000
+15,000
+60% +$516K 0.05% 241
2021
Q3
$1.03M Buy
25,000
+5,000
+25% +$274K 0.06% 237
2021
Q2
$1.13M Hold
20,000
0.06% 225
2021
Q1
$840K Buy
20,000
+10,000
+100% +$570K 0.05% 253
2020
Q4
$701K Buy
+10,000
New +$411K 0.05% 275

Other funds holding EDIT